Pharmacotherapeutics and Vaccines for COVID-19
Identification: MSNJ2212
Issue: May-June 2022
Volume: Vol. 31/No. 3
Credits (Post Test and/or Evaluation Required)
Available until 06/30/2024
- 1.30 - CH
- 1.25 - Rx
Description
Learning Outcome:
After completing this education activity, the learner will be able to gain an understanding of the vital role of nurses in pharmacovigilance and drug safety, especially in the administration of new drugs for COVID-19.
Contact hours available until 6/30/2024.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers, authors):
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.
Commercial Support:
No commercial support or sponsorship declared.
Accreditation Statement:
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.
Author(s):
- Ergie P. Inocian, EdD, RN, CMSRN, CNOR
- Ejay H. Ignacio, MSN, RN, CNOR
- Isabelita N. Pandaan, EdD, RN
- Rhea Faye D. Felicilda Reynaldo, EdD, RN
Credits Available
- 1.30 - CH
- 1.25 - Rx
You must be logged in and own this product in order to post comments.
Julie Arebun
7/25/22 11:53 am
Very Informative
Sandra Slonosky
8/22/22 10:40 am
Very informative. We are following these guidelines in our hospital. We are having trouble getting patients back to nursing homes because they want a negative covid test and as from this article and research shows they can be positive up to 3 months.
Lucille Carmeli Lorea
9/2/22 4:41 pm
informative
Binu Ellankil
9/15/22 9:22 am
Good Information, we are following the standardguidlines
Sandra Clark
9/15/22 5:03 pm
Good reminder of what we need to do to stand together and encourage immunizations.
Tamera Hussey
11/13/22 7:36 pm
Great article. Our facility is following these standards. Nursing homes are requiring negative test in our area. Article reports can be 3 months test positive.
Van Bellew
2/15/23 8:25 pm
We've come so far since the beginning... Great review and can't emphasize enough the RN role in public health prevention and maintenance.
Maria Libano
6/9/23 4:08 pm
Excellent article.
Sara Groff
10/30/23 9:36 am
Important to ensure that with changing information for both patients and associates, organizations stay proactive on communication and findings
Melvin Cruz
7/23/22 11:06 am
Healthcare facilities housing patients with COVID-19 should adhere to standard guidelines. Medical-surgical nurses are in an optimal position to advocate for effective treatment modalities and preventive measures for this disease. Nurses have a vital role in pharmacovigilance and drug safety, especially in administering new drugs for COVID-19